2021 Q3 Form 10-Q Financial Statement
#000114036121037751 Filed on November 15, 2021
Income Statement
| Concept | 2021 Q3 | 2020 Q3 |
|---|---|---|
| Revenue | $1.674M | $225.4K |
| YoY Change | 642.64% | |
| Cost Of Revenue | $1.646M | $90.48K |
| YoY Change | 1719.0% | |
| Gross Profit | $28.22K | $134.9K |
| YoY Change | -79.09% | |
| Gross Profit Margin | 1.69% | 59.86% |
| Selling, General & Admin | $13.04M | $886.6K |
| YoY Change | 1370.81% | 1673.26% |
| % of Gross Profit | 46215.58% | 657.08% |
| Research & Development | $893.2K | $37.64K |
| YoY Change | 2273.05% | |
| % of Gross Profit | 3165.52% | 27.89% |
| Depreciation & Amortization | $309.7K | $0.00 |
| YoY Change | ||
| % of Gross Profit | 1097.67% | 0.0% |
| Operating Expenses | $13.93M | $924.3K |
| YoY Change | 1407.56% | 477.67% |
| Operating Profit | -$13.71M | -$773.3K |
| YoY Change | 1672.73% | 370.98% |
| Interest Expense | -$28.80K | $40.00K |
| YoY Change | -172.0% | -96.61% |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$15.96K | $31.06K |
| YoY Change | -151.39% | |
| Pretax Income | -$11.33M | -$751.9K |
| YoY Change | 1406.9% | -174.08% |
| Income Tax | -$50.94K | -$3.101K |
| % Of Pretax Income | ||
| Net Earnings | -$11.28M | -$748.8K |
| YoY Change | 1406.34% | -191.86% |
| Net Earnings / Revenue | -673.82% | -332.2% |
| Basic Earnings Per Share | -$0.23 | -$0.03 |
| Diluted Earnings Per Share | -$0.23 | -$0.03 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 48.33M | 23.18M |
| Diluted Shares Outstanding | 48.33M | 23.18M |
Balance Sheet
| Concept | 2021 Q3 | 2020 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $92.49M | $100.0K |
| YoY Change | 92392.37% | -83.33% |
| Cash & Equivalents | $92.49M | $929.3K |
| Short-Term Investments | ||
| Other Short-Term Assets | $3.767M | $0.00 |
| YoY Change | ||
| Inventory | $5.599M | |
| Prepaid Expenses | $1.823M | |
| Receivables | $6.506M | |
| Other Receivables | $1.424M | |
| Total Short-Term Assets | $108.4M | $100.0K |
| YoY Change | 108264.1% | -84.14% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $7.883M | |
| YoY Change | ||
| Goodwill | $29.40M | |
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $3.435M | $153.8M |
| YoY Change | -97.77% | -31.49% |
| Total Long-Term Assets | $65.60M | $153.8M |
| YoY Change | -57.35% | -31.5% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $108.4M | $100.0K |
| Total Long-Term Assets | $65.60M | $153.8M |
| Total Assets | $174.0M | $153.9M |
| YoY Change | 13.04% | -31.64% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $5.523M | $100.0K |
| YoY Change | 5422.62% | 538.24% |
| Accrued Expenses | $7.596M | $0.00 |
| YoY Change | -100.0% | |
| Deferred Revenue | $28.83K | |
| YoY Change | ||
| Short-Term Debt | $0.00 | $2.300M |
| YoY Change | -100.0% | |
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $15.41M | $2.400M |
| YoY Change | 542.1% | 184.36% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | $18.66M | $7.700M |
| YoY Change | 142.39% | 0.0% |
| Total Long-Term Liabilities | $18.66M | $7.700M |
| YoY Change | 142.39% | 0.0% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $15.41M | $2.400M |
| Total Long-Term Liabilities | $18.66M | $7.700M |
| Total Liabilities | $37.83M | $10.20M |
| YoY Change | 270.9% | 19.13% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$24.42M | |
| YoY Change | ||
| Common Stock | $5.125K | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $136.1M | -$553.0K |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $174.0M | $153.9M |
| YoY Change | 13.04% | -31.64% |
Cashflow Statement
| Concept | 2021 Q3 | 2020 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$11.28M | -$748.8K |
| YoY Change | 1406.34% | -191.86% |
| Depreciation, Depletion And Amortization | $309.7K | $0.00 |
| YoY Change | ||
| Cash From Operating Activities | -$8.459M | -$640.0K |
| YoY Change | 1221.7% | 1180.0% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$1.711M | $30.00K |
| YoY Change | -5802.43% | |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$12.89M | -$960.0K |
| YoY Change | 1242.85% | |
| Cash From Investing Activities | -$14.60M | -$960.0K |
| YoY Change | 1421.06% | |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | -4.110K | 1.580M |
| YoY Change | -100.26% | |
| NET CHANGE | ||
| Cash From Operating Activities | -8.459M | -640.0K |
| Cash From Investing Activities | -14.60M | -960.0K |
| Cash From Financing Activities | -4.110K | 1.580M |
| Net Change In Cash | -23.07M | -20.00K |
| YoY Change | 115225.55% | -60.0% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$8.459M | -$640.0K |
| Capital Expenditures | -$1.711M | $30.00K |
| Free Cash Flow | -$6.748M | -$670.0K |
| YoY Change | 907.18% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2021 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001744494 | ||
| CY2021Q3 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
1279969 | |
| CY2020Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
0 | |
| CY2021Q3 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
3756859 | |
| CY2020Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
0 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
25033398 | |
| CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
2503 | |
| CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
3687534 | |
| CY2021Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2021Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2021Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
51253591 | |
| CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
25033398 | |
| CY2020Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
5125 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
110000000 | |
| CY2020Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2020Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
| CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
110000000 | |
| CY2021Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
51253591 | |
| CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
| CY2021Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
161263673 | |
| CY2020Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
10993762 | |
| CY2021Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-717328 | |
| CY2020Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
111780 | |
| CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-24418878 | |
| CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-12901518 | |
| CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
136132592 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1793473 | |
| CY2021Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
173964062 | |
| CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1894061 | |
| CY2021Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | |
| CY2021Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
| CY2021Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1673998 | |
| CY2020Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
225412 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
526032 | ||
| CY2021Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1645781 | |
| CY2020Q3 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
90477 | |
| us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
2662476 | ||
| us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
374430 | ||
| CY2021Q3 | us-gaap |
Gross Profit
GrossProfit
|
28217 | |
| CY2020Q3 | us-gaap |
Gross Profit
GrossProfit
|
134934 | |
| us-gaap |
Gross Profit
GrossProfit
|
1504278 | ||
| us-gaap |
Gross Profit
GrossProfit
|
151602 | ||
| CY2021Q3 | adn |
Income From Grants
IncomeFromGrants
|
507606 | |
| CY2020Q3 | adn |
Income From Grants
IncomeFromGrants
|
16076 | |
| adn |
Income From Grants
IncomeFromGrants
|
631787 | ||
| adn |
Income From Grants
IncomeFromGrants
|
159182 | ||
| CY2020Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
37640 | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1561049 | ||
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
81273 | ||
| CY2021Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
13040649 | |
| CY2020Q3 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
886629 | |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
27558242 | ||
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1641063 | ||
| CY2021Q3 | adn |
Amortization And Reversal Of Amortization Of Intangible Assets
AmortizationAndReversalOfAmortizationOfIntangibleAssets
|
309734 | |
| CY2020Q3 | adn |
Amortization And Reversal Of Amortization Of Intangible Assets
AmortizationAndReversalOfAmortizationOfIntangibleAssets
|
0 | |
| adn |
Amortization And Reversal Of Amortization Of Intangible Assets
AmortizationAndReversalOfAmortizationOfIntangibleAssets
|
467447 | ||
| adn |
Amortization And Reversal Of Amortization Of Intangible Assets
AmortizationAndReversalOfAmortizationOfIntangibleAssets
|
0 | ||
| CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13707773 | |
| CY2020Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-773258 | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-27450673 | ||
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1411552 | ||
| CY2021Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
13542 | |
| CY2020Q3 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
1712 | |
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
26961 | ||
| us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
4749 | ||
| CY2021Q3 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
2421874 | |
| CY2020Q3 | us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | |
| adn |
Payments To Acquire Fixed Assets
PaymentsToAcquireFixedAssets
|
1917856 | ||
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
19425378 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-24001818 | ||
| us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-89123 | ||
| adn |
Proceeds From Shares Issued In Business Combination
ProceedsFromSharesIssuedInBusinessCombination
|
141120851 | ||
| adn |
Proceeds From Shares Issued In Business Combination
ProceedsFromSharesIssuedInBusinessCombination
|
0 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
141496405 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
882311 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
92804258 | ||
| us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
89123 | ||
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-827624 | ||
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
|
-17918 | ||
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
515734 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1199015 | |
| CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
92492367 | |
| CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
929283 | |
| us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div> <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-weight: bold; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">1.</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0); font-weight: bold;">Basis of presentation</div> </td> </tr> </table> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">(a)</td> <td style="width: auto; vertical-align: top; text-align: justify;"> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Overview</div> </td> </tr> </table> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On February 4, 2021 (“Closing Date”), AMCI Acquisition Corp. (“AMCI”), consummated the previously announced business combination (the “Business Combination”) pursuant to that certain merger agreement (the “Agreement and Plan of Merger”), dated October 12, 2020, by and among AMCI, AMCI Merger Sub Corp., a Delaware corporation and newly formed wholly-owned subsidiary of AMCI (“Merger Sub”), AMCI Sponsor LLC (the “Sponsor”), solely in the capacity as the representative from and after the effective time of the Business Combination for the stockholders of AMCI (the “Purchaser Representative”), Advent Technologies, Inc., a Delaware corporation (“Legacy Advent”), and Vassilios Gregoriou, solely in his capacity as the representative from and after the effective time for the Legacy Advent stockholders (the “Seller Representative”), as amended by Amendment No. 1 and Amendment No. 2 to the Agreement and Plan of Merger, dated as of October 19, 2020 and December 31, 2020, respectively, by and among AMCI, Merger Sub, Sponsor, Legacy Advent, and Seller Representative. In connection with the closing of the Business Combination (the “Closing”), AMCI acquired 100% of the stock of Legacy Advent (as it existed immediately prior to the Closing) and its subsidiaries.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On the Closing Date, and in connection with the closing of the Business Combination, AMCI changed its name to Advent Technologies Holdings, Inc. (the "Company" or "Advent"). Legacy Advent was deemed the accounting acquirer in the Business Combination based on an analysis of the criteria outlined in Accounting Standards Codification ("ASC") 805. This determination was primarily based on Legacy Advent's stockholders prior to the Business Combination having a majority of the voting interests in the combined company, Legacy Advent's operations comprising the ongoing operations of the combined company, Legacy Advent's board of directors comprising a majority of the board of directors of the combined company, and Legacy Advent's senior management comprising the senior management of the combined company. Accordingly, for accounting purposes, the Business Combination was treated as the equivalent of Legacy Advent issuing stock for the net assets of AMCI, accompanied by a recapitalization. The net assets of AMCI are stated at historical cost, with no goodwill or other intangible assets recorded.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">While AMCI was the legal acquirer in the Business Combination, because Legacy Advent was deemed the accounting acquirer, the historical financial statements of Legacy Advent became the historical financial statements of the combined company, upon the consummation of the Business Combination. As a result, the unaudited condensed consolidated financial statements included in this report reflect (i) the historical operating results of Legacy Advent prior to the Business Combination; (ii) the results of the Company (combined results of AMCI and Legacy Advent) following the closing of the Business Combination; (iii) the assets and liabilities of Legacy Advent at their historical cost; and (iv) Company’s equity structure for all periods presented.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In accordance with guidance applicable to these circumstances, the equity structure has been restated in all comparative periods up to the Closing Date, to reflect the number of shares of the Company's common stock, $0.0001 par value per share ("Common Stock") issued to Legacy Advent's stockholders in connection with the recapitalization transaction. As such, the shares and corresponding capital amounts and earnings per share related to Legacy Advent Preferred Stock (“Preferred Series A” and “Preferred Series Seed”) and Legacy Advent common stock prior to the Business Combination have been retroactively restated as shares reflecting the exchange ratio established in the Business Combination Agreement. Activity within the statement of changes in stockholders' equity / (deficit) for the issuances of Legacy Advent's Preferred Stock, were also retroactively converted to Legacy Advent common stock. (Note 3).</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On February 18, 2021, the Company, entered into a Membership Interest Purchase Agreement with Bren-Tronics, Inc. (“Seller”) and UltraCell, LLC, a Delaware limited liability company and a direct wholly-owned subsidiary of Seller (“UltraCell”) (the “Purchase Agreement”). See Note 3 “Business Combination” </span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">accompanying the unaudited condensed consolidated financial statements for additional information.</span></div> <div style="text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-family: 'Times New Roman';">On June 25, 2021, the Company entered into a Share Purchase Agreement (the “Purchase Agreement”), with F.E.R. fischer Edelstahlrohre GmbH, a limited liability company incorporated under the Laws of Germany (the “Seller”) to acquire (the “Acquisition”) all of the issued and outstanding equity interests in SerEnergy A/S, a Danish stock corporation and a wholly-owned subsidiary of the Seller (“SerEnergy”) and fischer eco solutions GmbH, a German limited liability company and a wholly-owned subsidiary of the Seller (“FES” and together with SerEnergy, the “Target Companies”) together with certain outstanding shareholder loan receivables. See Note 3 “Business Combination” accompanying the unaudited condensed consolidated financial statements for additional information.</span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> <span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">(b)</td> <td style="width: auto; vertical-align: top; text-align: justify;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Unaudited Condensed Consolidated Financial Statements</div> </td> </tr> </table> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and pursuant to the regulations of the U.S. Securities and Exchange Commission (“SEC”). The unaudited financial information reflects, in the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial position, results of operations and cash flows for the periods indicated. The results reported for the interim period presented are not necessarily indicative of results that may be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's audited consolidated financial statements as of and for the year ended December 31, 2020 included in the Current Report on Form 8-K filed with the SEC on February 9, 2021 (the “Original Form 8-K”), as amended by Amendment No. 1 to Form 8-K, filed with the SEC on February 9, 2021 (“Amendment No. 1”), as further amended by Amendment No. 2 to Form 8-K, filed with the SEC on March 26, 2021 (“Amendment No. 2”) and as further amended by Amendment No 3 to Form 8-K, filed with the SEC on May 20, 2021 (“Amendment No. 3,” and, the Original Form 8-K, as so amended by Amendment No. 1, Amendment No. 2 and Amendment No. 3, the “Super Form 8-K”).</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany accounts and transactions have been eliminated.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain prior period balances have been reclassified to conform to the current period presentation in the unaudited condensed consolidated financial statements and the accompanying notes.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Share and per share amounts are presented on a post-conversion basis for all periods presented, unless otherwise specified.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <tr style="vertical-align: top;"> <td style="vertical-align: top; width: 18pt;"> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">(c)</div> </td> <td style="align: left; vertical-align: top; width: auto;"> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Going Concern</div> </td> </tr> </table> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The unaudited condensed consolidated financial statements have been prepared by management in accordance with GAAP, assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. Accordingly, these financial statements do not include any adjustments that may result in the event the Company is unable to continue as a going concern.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Beginning in March 2020, the COVID-19 pandemic and the measures imposed to contain this pandemic have disrupted and are expected to continue to impact the Company’s business. The magnitude of the impact of the COVID-19 pandemic on the Company’s productivity, results of operations and financial position, and its disruption to the Company’s business (fuel cells sales timeline, realization of income from grants received) will depend in part, on the length and severity of these restrictions and on the Company’s ability to conduct business in the ordinary course.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">As of the date of this Quarterly Report on Form 10-Q, the Company’s existing cash resources are sufficient to support planned operations for the next 12 months. As a result, management believes that the Company's existing financial resources are sufficient to continue operating activities for at least one year past the issuance date of the unaudited condensed consolidated financial statements.</div> | ||
| CY2021Q3 | us-gaap |
Liabilities
Liabilities
|
37831470 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4166754 | ||
| CY2021Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
893215 | |
| us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
15833334 | ||
| us-gaap |
Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
|
0 | ||
| CY2021Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-15256 | |
| CY2020Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
31058 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-1418037 | ||
| CY2021Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-11820594 | |
| CY2021Q2 | adn |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest Before Recapitalization Transaction
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalizationTransaction
|
106653709 | |
| CY2021Q3 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
37923860 | |
| CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-540871 | |
| CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
136132592 | |
| CY2020Q4 | adn |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest Before Recapitalization Transaction
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalizationTransaction
|
-1793473 | |
| adn |
Stock Issued During Period Value Acquisitions And Private Investment In Public Equity
StockIssuedDuringPeriodValueAcquisitionsAndPrivateInvestmentInPublicEquity
|
108007984 | ||
| us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
37923860 | ||
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
69430 | ||
| us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
0 | ||
| us-gaap |
Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
|
<div> <span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">(b)</td> <td style="width: auto; vertical-align: top; text-align: justify;"><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"> </span> <div style="color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Warrants</div> </td> </tr> </table> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company may issue or assume common stock warrants with debt, equity or as standalone financing instruments that are recorded as either liabilities or equity in accordance with the respective accounting guidance. Warrants recorded as equity are recorded at their relative fair value or fair value determined at the issuance date and remeasurement is not required. Warrants recorded as liabilities are recorded at their fair value, within warrant liability on the consolidated balance sheets, and remeasured on each reporting date with changes recorded in revaluation of warrant liability on the Company's consolidated statements of operations.</div> | ||
| CY2020Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-8005 | |
| us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-2141 | ||
| us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-26584 | ||
| CY2021Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-15960 | |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
78146 | ||
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
24848 | ||
| CY2021Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-11330657 | |
| CY2020Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-751917 | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-11568295 | ||
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1418037 | ||
| CY2021Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
50935 | |
| CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3101 | |
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
50935 | ||
| us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | ||
| CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11279722 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-748816 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-11517360 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-1418037 | ||
| CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.23 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.26 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | ||
| CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
48325164 | |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
23182817 | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
43982039 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21180639 | ||
| CY2021Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.23 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.26 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | ||
| CY2021Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
48325164 | |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
23182817 | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
43982039 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21180639 | ||
| CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11279722 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-748816 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-11517360 | ||
| CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-540871 | |
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-2042 | |
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-829108 | ||
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-13544 | ||
| CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-540871 | |
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-2042 | |
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-829108 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-13544 | ||
| CY2020Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-750858 | |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-12346468 | ||
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1431581 | ||
| CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3375616 | |
| CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11279722 | |
| CY2020Q4 | adn |
Stockholders Equity Recapitalization Of Reporting Entity
StockholdersEquityRecapitalizationOfReportingEntity
|
0 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1793473 | |
| adn |
Stock Issued During Period Issued For Warrant Exercises
StockIssuedDuringPeriodIssuedForWarrantExercises
|
262177 | ||
| us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
4078513 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-11517360 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-829108 | ||
| CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
136132592 | |
| CY2020Q2 | adn |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest Before Recapitalization Transaction
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalizationTransaction
|
-13150 | |
| CY2020Q3 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
8935 | |
| CY2020Q3 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
34593 | |
| CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
236628 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-748816 | |
| CY2020Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-2042 | |
| CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-553039 | |
| CY2019Q4 | adn |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest Before Recapitalization Transaction
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestBeforeRecapitalizationTransaction
|
-833802 | |
| CY2019Q4 | adn |
Stockholders Equity Recapitalization Of Reporting Entity
StockholdersEquityRecapitalizationOfReportingEntity
|
0 | |
| CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-833802 | |
| us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1430005 | ||
| us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
21736 | ||
| us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
152792 | ||
| us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
413396 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-1418037 | ||
| us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
-13544 | ||
| CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-553039 | |
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-24690329 | ||
| us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1045004 | ||
| us-gaap |
Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
|
2658584 | ||
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
0 | ||
| adn |
Payments To Acquire Fixed Assets
PaymentsToAcquireFixedAssets
|
0 | ||
| us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
0 | ||
| us-gaap |
Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
|
1430005 | ||
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
|
0 | ||
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
|
21736 | ||
| us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | ||
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
262177 | ||
| us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | ||
| us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
113377 | ||
| us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | ||
| us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
500000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-251815 | ||
| adn |
Recognition Of Stock Grant Plans
RecognitionOfStockGrantPlans
|
4078513 | ||
| adn |
Recognition Of Stock Grant Plans
RecognitionOfStockGrantPlans
|
413396 | ||
| us-gaap |
Number Of Reporting Units
NumberOfReportingUnits
|
1 | ||
| CY2021Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
5522624 | |
| CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
881394 | |
| CY2021Q3 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
5598574 | |
| CY2020Q4 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
107939 | |
| CY2021Q3 | us-gaap |
Inventory Net
InventoryNet
|
5598574 | |
| CY2020Q4 | us-gaap |
Inventory Net
InventoryNet
|
107939 | |
| CY2021Q3 | us-gaap |
Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
|
30000 | |
| CY2020Q4 | us-gaap |
Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
|
1114659 | |
| CY2021Q3 | us-gaap |
Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
|
0 | |
| CY2020Q4 | us-gaap |
Due From Officers Or Stockholders Current
DueFromOfficersOrStockholdersCurrent
|
67781 | |
| us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
5600000 | ||
| CY2021Q3 | adn |
Trade Payables And Other Payables Current
TradePayablesAndOtherPayablesCurrent
|
5522624 | |
| us-gaap |
Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
|
2700000 | ||
| CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
167761 | |
| CY2021Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1673998 | |
| CY2020Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
225412 | |
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
4166754 | ||
| us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
526032 | ||
| CY2021Q3 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
936259 | |
| CY2020Q4 | us-gaap |
Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
|
85930 | |
| CY2021Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
28832 | |
| CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11279722 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-748816 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-11517360 | ||
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-1418037 | ||
| CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
48325164 | |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
23182817 | |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
43982039 | ||
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
21180639 | ||
| CY2021Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
48325164 | |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
23182817 | |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
43982039 | ||
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
21180639 | ||
| CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.23 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.26 | ||
| us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | ||
| CY2021Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.23 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | |
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.26 | ||
| us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | ||
| CY2021Q3 | us-gaap |
Value Added Tax Receivable
ValueAddedTaxReceivable
|
826973 | |
| CY2020Q4 | us-gaap |
Value Added Tax Receivable
ValueAddedTaxReceivable
|
259831 | |
| CY2021Q3 | us-gaap |
Grants Receivable
GrantsReceivable
|
597155 | |
| CY2020Q4 | us-gaap |
Grants Receivable
GrantsReceivable
|
95064 | |
| CY2021Q3 | us-gaap |
Other Receivables Gross Current
OtherReceivablesGrossCurrent
|
520007 | |
| CY2020Q4 | us-gaap |
Other Receivables Gross Current
OtherReceivablesGrossCurrent
|
140126 | |
| CY2021Q3 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
1822962 | |
| CY2020Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
1724 | |
| CY2021Q3 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
3767096 | |
| CY2020Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
496745 | |
| CY2020Q4 | adn |
Trade Payables And Other Payables Current
TradePayablesAndOtherPayablesCurrent
|
881394 | |
| CY2021Q3 | adn |
Executive Severance Payable
ExecutiveSeverancePayable
|
1800000 | |
| CY2021Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5124846 | |
| CY2021Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
51253591 | |
| CY2021Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1110587 | |
| CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
814965 | |
| CY2021Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
6485032 | |
| CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
89414 | |
| CY2021Q3 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
7595619 | |
| CY2020Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
904379 | |
| CY2021Q3 | adn |
Business Combination Consideration Payable Cash
BusinessCombinationConsiderationPayableCash
|
4366802 | |
| CY2021Q3 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
127104 | |
| CY2021Q3 | us-gaap |
Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
|
940972 | |
| CY2021Q3 | us-gaap |
Product Warranty Accrual
ProductWarrantyAccrual
|
1068076 | |
| CY2021Q3 | adn |
Percentage Of Accrued Warranty Reserve On Sale Price Of Goods Sold
PercentageOfAccruedWarrantyReserveOnSalePriceOfGoodsSold
|
0.08 | |
| CY2021Q3 | adn |
Number Of Shares Authorized
NumberOfSharesAuthorized
|
111000000 | |
| CY2021Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
110000000 | |
| CY2021Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2021Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
| CY2021Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
51253591 | |
| CY2021Q3 | us-gaap |
Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
|
2776164 | |
| CY2021Q1 | us-gaap |
Area Of Real Estate Property
AreaOfRealEstateProperty
|
6041 | |
| CY2021Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
456095 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P5Y | |
| CY2021Q1 | us-gaap |
Area Of Real Estate Property
AreaOfRealEstateProperty
|
21401 | |
| CY2021Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1498070 | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P8Y5M | |
| CY2021Q1 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P5Y | |
| CY2021Q1 | us-gaap |
Security Deposit
SecurityDeposit
|
750000 | |
| CY2021Q3 | us-gaap |
Area Of Real Estate Property
AreaOfRealEstateProperty
|
1017 | |
| CY2021Q3 | adn |
Operating Lease Monthly Basic Rate Plus Vat
OperatingLeaseMonthlyBasicRatePlusVAT
|
7768 |
